Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Shareholder Information

Oxurion is listed on Euronext Brussels under the symbol OXUR.

As of 5 January 2018, Oxurion has a total number of 38,271,575 outstanding shares and a total number of 848,875 warrants.

KBC Bank is acting as the paying agent. The paying agent will not charge shareholders with respect to payments of dividends, the exercise of subscription rights and other events concerning Oxurion shares. Shareholders should inform themselves about the amounts that other financial intermediaries may charge in connection with paying agency services.

View Shareholders History of Capital


Extraordinary and ordinary shareholders meeting
  • Convocation of the extraordinary shareholders' meeting on September 3, 2018 - View document
  • Proxy form for the extraordinary shareholders' meeting - View document
  • Shareholders' rights pursuant to art.533ter and 540 BCC - View document
  • Convocation of the extraordinary shareholders' meeting on July 27, 2018 - View document
  • Proxy form for the extraordinary shareholders' meeting - View document
  • Shareholders' rights pursuant to art.533ter and 540 BCC - View document

Archive